Valiant Laboratories’s IPO will hit the market 27 September 2023 ans closes on 03 October 2023. Valiant Laboratories IPO GMP Kostak rate and subject to sauda updated as of today. The Valiant Laboratories IPO Grey Market Premium has not started at this time, but as some movement is possible soon, we need to wait for the rates to change with the market sentiment in a few days or to stabilise the rates. You can check Valiant Laboratories IPO subscription status here.
Valiant Laboratories Limited is an Active Pharmaceutical Ingredient (“API”) / Bulk Drug manufacturing company. The manufacturing of Paracetamol Bulk drugs/Active Pharmaceutical Ingredients (API) serve as raw materials for manufacturing finished dosage forms or formulations.
The pharmaceutical API industry in India is ranked third-largest globally in terms of volume, behind China and Italy – About 35 per cent of API and intermediaries produced in India are exported and the remaining API and intermediaries are sold in the domestic market, including captive consumption by several large formulation players.
Valiant Laboratories IPO Issue size of ₹152.46 Crores, in which Fresh Issue of ₹152.46 Crores and issue price band has been fixed at ₹133 to ₹140 Per Share. The Valiant Laboratories IPO to be listed Soon on NSE and BSE.
What is Valiant Laboratories IPO GMP Today?
■ The Valiant Laboratories IPO GMP Today Or Grey Market Premium is ₹24-₹25.
What is Valiant Laboratories IPO Kostak Rates Today?
■ The Valiant Laboratories IPO Kostak rate is ₹0.
What is Valiant Laboratories IPO Subject to Sauda Price Today?
■ The Valiant Laboratories IPO Subject to Sauda rates is ₹2000.
Valiant Laboratories IPO Approximately Returns?
■ The Valiant Laboratories IPO’s approximate return is 5%-10%, and it can also change according to the Market Sentiment.
Valiant Laboratories IPO GMP Live, Kostak, & Subject :
| Date | GMP | Kostak | Subject |
| 06 Oct 2023 | List: ₹162.15 Gain: 15.82% | ₹0 | ₹1600 |
| 05 Oct 2023 | ₹20-₹21  | ₹0 | ₹1600 |
| 04 Oct 2023 | ₹24-₹25  | ₹0 | ₹2000 |
| 03 Oct 2023 | ₹15-₹16  | ₹0 | ₹1200 |
| 02 Oct 2023 | ₹15-₹16 | ₹0 | ₹1200 |
| 01 Oct 2023 | ₹15-₹16 | ₹0 | ₹1200 |
| 30 Sep 2023 | ₹15-₹16 | ₹0 | ₹1400 |
| 29 Sep 2023 | ₹15-₹16 | ₹0 | ₹1400 |
| 28 Sep 2023 | ₹16-₹17 | ₹0 | ₹800 |
| 27 Sep 2023 | ₹8-₹9 | ₹0 | ₹0 |
| 26 Sep 2023 | ₹0-₹0 | ₹0 | ₹0 |
| 25 Sep 2023 | ₹0-₹0 | ₹0 | ₹0 |
| 24 Sep 2023 | ₹0-₹0 | ₹0 | ₹0 |
| 23 Sep 2023 | ₹0-₹0 | ₹0 | ₹0 |
| 22 Sep 2023 | ₹0-₹0 | ₹0 | ₹0 |
IPO GMP Facts :
- The GMP is usually higher for IPOs of well-known companies with strong fundamentals.
- The GMP is also likely to be higher for IPOs that are heavily subscribed.
- It is important to do your own research before investing in an IPO, regardless of the GMP.
Valiant Laboratories IPO GMP FAQs :
How much is Valiant Laboratories IPO GMP Today?
Valiant Laboratories IPO GMP Today is ₹24-₹25.
How much is Valiant Laboratories IPO Grey Market Premium today?
Valiant Laboratories IPO is Grey Market Premium ₹24-₹25.
What is Valiant Laboratories IPO Kostak Rate?
Valiant Laboratories IPO Kostak Rate is ₹0.
What is Valiant Laboratories IPO Subject to Sauda?
Valiant Laboratories IPO Subject to Deals is ₹2000.
What are Valiant Laboratories IPO Approx Returns?
Valiant Laboratories IPO approx Returns is 5%-10%, and it can also change according to the Market Sentiment.
IPO GMP Disclaimer :
- GMP is not an indicator of the final listing price : The GMP is just a reflection of the demand and supply of the IPO shares in the grey market. The final listing price will depend on a number of factors, including the overall market sentiment and the performance of the company in the post-IPO period.
- The GMP can be volatile : The GMP can fluctuate significantly in the days leading up to the IPO listing. This is due to the uncertainty surrounding the final listing price and the volatility of the stock market in general.
- There is no guarantee of profit : Even if the GMP is high, there is no guarantee that the IPO shares will list at a profit. The final listing price could be lower than the GMP, or the shares could even decline in value after listing.
- Investing in IPOs carries risks : IPOs are considered to be high-risk investments. There is always the possibility that the company could fail, or that the shares could be diluted in the future.
| Valiant Laboratories IPO Details: Click Here Valiant Laboratories IPO Subscription: Click Here Valiant Laboratories IPO Allotment: Click Here Valiant Laboratories IPO Listing: Click Here |
All Valiant Laboratories IPO-related links are available here. If you want to know the details then click on Click Here Link.
Disclaimer: STOCK MARKET INVESTMENTS ARE SUBJECT TO MARKET RISKS, READ ALL SCHEME RELATED DOCUMENTS CAREFULLY BEFORE INVESTING.